ACTA1 and Alzheimer disease: Another study [38] revealed that overexpression of circTGFBR2 in VSMCs associated with AD leads to an increase in the expression of contraction markers (α-SMA and SM22α), while synthetic markers (MGP and OPN) are down-regulated.